Dupilumab (Dupixent▼): risk of ocular adverse reactions and need for prompt management

2022-11-29T14:00:26+00:00

Healthcare professionals prescribing dupilumab should be alert to the risks of ocular reactions. New onset or worsening ocular symptoms require prompt review. Referral for ophthalmological examination should be made as appro…